Back to search

Article

Harnessing Escherichia coli’s Dark Genome to Produce Anti-Alzheimer Peptides

2023-06-24

Abstract excerpt

Alzheimer’s disease (AD) is characterized by progressive neurodegeneration. The critical molecular trigger is believed to be the accumulation of Aβ neurotoxic oligomers. Given the proteolytic processing of Amyloid Precursor Protein (APP) by β-secretase (beta-site APP cleaving enzyme 1, BACE1) as the key step in the building up of Aβ oligomers, BACE inhibitors come with therapeutic prospects of preventing or delayi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
726c6638-416d-554f-833b-cfeada9d47d8
DOI
10.1101/2023.06.23.546343
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Harnessing Escherichia coli’s Dark Genome to Produce Anti-Alzheimer PeptidesDOI 10.1101/2023.06.23.546343
Select a neighboring publication to make it the new centre.